Inspired by traditional medicine, 17-year-old Tomás Orellana is on a mission to identify plants that can help treat students’ health issues.

Study reveals the drug, 5-fluorouracil, acts differently in different types of cancer — a finding that could help researchers design better drug combinations.

The scientists, who worked together as postdocs at MIT, are honored for their discovery of microRNA — a class of molecules that are critical for gene regulation.

Advisors commended for providing exceptional individualized mentoring for postdocs.

Elemind, founded by researchers from MIT, has developed a headband that uses acoustic stimulation to move people into a sleep state.

MIT researchers identify facility-level factors that could worsen heat impacts for incarcerated people.

The innovations map the ocean floor and the brain, prevent heat stroke and cognitive injury, expand AI processing and quantum system capabilities, and introduce new fabrication approaches.

New statistical models based on physiological data from more than 100 surgeries provide objective, accurate measures of the body’s subconscious perception of pain.

Researchers argue that in health care settings, “responsible use” labels could ensure AI systems are deployed appropriately.

MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.

MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.

MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.

Hanna Adeyema and Carolina Haass-Koffler discuss the substance use disorder crisis and the future of innovation in the field.

The night of festivities featured students showcasing their startups’ progress, along with a lively reception.

MIT researchers investigate the neural circuits that underlie placebos’ ability to relieve chronic and acute pain.

“ScribblePrompt” is an interactive AI framework that can efficiently highlight anatomical structures across different medical scans, assisting medical workers to delineate regions of interest and abnormalities.

In animal models, even low stimulation currents can sometimes still cause electrographic seizures, researchers found.

PhD student Oscar Molina seeks new ways to assemble proteins into targeted cancer therapies, while also encouraging his fellow first-generation graduate students.

MD/PhD student Sayo Eweje seeks to develop new technologies for delivering RNA and protein therapies directly to the body’s cells.

By unraveling the genetic pathways that help Toxoplasma gondii persist in human cells, Sebastian Lourido hopes to find new ways to treat toxoplasmosis.

Fasting helps intestinal stem cells regenerate and heal injuries but also leads to a higher risk of cancer in mice, MIT researchers report.

Professor Ellen Roche is creating the next generation of medical devices to help repair hearts, lungs, and other tissues.

The new device, which can be implanted under the skin, rapidly releases naloxone when an overdose is detected.

Professor who uses a cross-disciplinary approach to understand human diseases on a molecular and cellular level succeeds Elazer Edelman.

A mathematical method, validated with experimental data, provides a fast, reliable, and minimally invasive way of determining how to treat critical blood pressure changes during surgery or intensive care.

The company that brought you no-stick toothpaste is moving into the medical space, with a lubricant for ostomy pouches and other products that could improve millions of lives.

The model could help clinicians assess breast cancer stage and ultimately help in reducing overtreatment.

The model could help clinicians assess breast cancer stage and ultimately help in reducing overtreatment.

Propofol, a drug commonly used for general anesthesia, derails the brain’s normal balance between stability and excitability.

More accurate uncertainty estimates could help users decide about how and when to use machine-learning models in the real world.

Staff members receive recognition for their exceptional support of the MIT community.

While women and men self-reported similar vaccination rates, unvaccinated women had less intention to get vaccinated than men.

A chip the size of a pack of cards uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable cell therapy manufacturing.

A chip the size of a pack of cards uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable cell therapy manufacturing.

By helping microbes withstand industrial processing, the method could make it easier to harness the benefits of microorganisms used as medicines and in agriculture.

This tiny, biocompatible sensor may overcome one of the biggest hurdles that prevent the devices from being completely implanted.

The minimally invasive, 3d-printable device offers safer application and removal, along with improved bioelectronic performance.

These models, which can predict a patient’s race, gender, and age, seem to use those traits as shortcuts when making medical diagnoses.

By designing new tools that can analyze huge libraries of immune cells and their targets, Michael Birnbaum hopes to generate better T cell therapies for cancer and other diseases.

A new gene-silencing tool shows promise as a future therapy against prion diseases and paves the way for new approaches to treating disease.

The program focused on AI in health care, drawing on Takeda’s R&D experience in drug development and MIT’s deep expertise in AI.

Leuko, founded by a research team at MIT, is giving doctors a noninvasive way to monitor cancer patients’ health during chemotherapy — no blood tests needed.

By capturing short-lived RNA molecules, scientists can map relationships between genes and the regulatory elements that control them.

An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.

Senior Hanjun Lee planned to pursue chemistry at MIT. A course in genetics changed that.

Ashutosh Kumar, a materials science and engineering PhD student and MathWorks Fellow, applies his eclectic skills to studying the relationship between bacteria and cancer.

New CLAUDIA system could continuously monitor patients during an infusion and adjust dosage to maintain optimal drug levels.

Immunai’s founders were researchers at MIT when they launched their company to help predict how patients will respond to new treatments.

In MIT’s 2024 Killian Lecture, chemical engineer Paula Hammond described her groundbreaking work on nanoparticles designed to attack tumor cells.

MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.